7 December 2015 - Labour leader Andrew Little says the drug Keytruda [pembrolizumab] used for treating melanoma should be funded for the next two years and then reviewed.

For more details, go to: http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11556985